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Abstract: Previous studies have reported that a diet containing 10% cocoa, a rich source  
of flavonoids, has immunomodulatory effects on rats and, among others effects, is able to 
attenuate the immunoglobulin (Ig) synthesis in both systemic and intestinal compartments. 
The purpose of the present study was focused on investigating whether these effects were 
attributed exclusively to the flavonoid content or to other compounds present in cocoa. To 
this end, eight-week-old Lewis rats were fed, for two weeks, either a standard diet or three 
isoenergetic diets containing increasing proportions of cocoa flavonoids from different 
sources: one with 0.2% polyphenols from conventional defatted cocoa, and two others with 
0.4% and 0.8% polyphenols, respectively, from non-fermented cocoa. Diet intake and body 
weight were monitored and fecal samples were obtained throughout the study to determine 
fecal pH, IgA, bacteria proportions, and IgA-coated bacteria. Moreover, IgG and IgM 
concentrations in serum samples collected during the study were quantified. At the end of 
the dietary intervention no clear changes of serum IgG or IgM concentrations were 
quantified, showing few effects of cocoa polyphenol diets at the systemic level. However, 
in the intestine, all cocoa polyphenol-enriched diets attenuated the age-related increase of 
both fecal IgA and IgA-coated bacteria, as well as the proportion of bacteria in feces. As 
these effects were not dependent on the dose of polyphenol present in the diets, other 
compounds and/or the precise polyphenol composition present in cocoa raw material used 
for the diets could be key factors in this effect. 
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1. Introduction 
Cocoa, obtained from dried and fermented seeds derived from Theobroma cacao, was consumed  
as early as 1100 B.C. by ancient Mesoamerican civilizations [1]. In fact, the Olmecs, and eventually 
the Mayans and Aztecs, consumed food and beverages produced from cocoa, which was considered a 
divine beverage with medicinal properties [2]. Although health benefits of cocoa were already known  
by these ancient civilizations, it was not until recently that cocoa gained recognition because of its high 
content of fiber and polyphenols, particularly flavonoids. Cocoa powder mainly contains flavanols 
such as (−)-epicatechin and (+)-catechin (5%–10% of total polyphenols) as well as procyanidins 
(≥90%), the oligomers derived from these monomers [3–11]. Other minor polyphenols have been 
identified in cocoa, e.g., quercetin, isoquercitrin (quercetin 3-O-glucoside), quercetin  
3-O-arabinose, hyperoside (quercetin 3-O-galactoside), naringenin, luteolin, apigenin, and others [12]. 
In addition to the antioxidant capacity of cocoa, its interaction with the immune system  
in vitro [13–16] and in vivo has been reported. Regarding in vivo effects, previous studies have 
demonstrated that a dietary intervention with cocoa was capable of modulating the serum IgA, IgM and 
IgG concentrations as well as the intestinal IgA and IgM contents in young rats [17–19]. In addition, a 
10% cocoa diet was able to modify the composition and functionality of several lymphoid  
tissues [17,20–22] including the gut-associated lymphoid tissue (GALT) [20,21]. Cocoa intake 
modified, at the same time, the fecal microbiota composition and its crosstalk with the immune system 
by means of the modulation of the toll-like receptors’ (TLR) gene expression in the colon [19]. 
As occurs in other plant-derived foods, the phenolic content of cocoa-derived products is  
largely dependent upon the cultivar, origin, agricultural and postharvest practices, and the  
processing [11,23,24]. Until the cocoa liquor is obtained, the cocoa seed has to be subjected to 
different procedures (specifically fermentation, alkalinization or Dutching and roasting processes) 
which lead to a considerable loss of cocoa polyphenols [9,11,24]. On account of the beneficial effects 
and the poor bioavailability of polyphenols, developing a new flavonoid-enriched cocoa powder has 
become a subject of great interest. In order to achieve this, control of the processing steps as well as 
some modifications of its habitual processing procedure have been proposed to keep the maximum 
amount of cocoa polyphenols [24]. To this end, Naturex S.A. developed CocoaPure, a new  
flavonoid-enriched cocoa powder from unfermented, blanch-treated, and non-roasted cocoa beans [25]. 
In this regard, two types of cocoa extracts with a different proportion and composition of 
polyphenols have been used to ascertain whether the cocoa modulatory effects on the systemic and 
intestinal immunoglobulin synthesis observed in previous studies can be attributed exclusively to its 
flavonoid content. 
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2. Material and Methods 
2.1. Animals and Diets 
Twenty-four male Lewis rats (8 weeks old) were obtained from Harlan (Barcelona, Spain) and 
housed in cages under conditions of controlled temperature and humidity in a 12:12 light-dark cycle. 
After one week of acclimatization, the rats were randomly assigned to four dietary groups  
(n = 6/each): the reference group (REF) which was fed with the standard diet AIN-93M (Harlan, 
Barcelona, Spain); the cocoa group (PC0.2), which received chow containing 0.2% of polyphenols 
from conventional cocoa powder; and the PC0.4 and PC0.8 groups, receiving 0.4% and 0.8% of 
polyphenols, respectively, from non-fermented cocoa (CocoaPure). The diet lasted two weeks. 
Conventional natural Forastero cocoa containing 21.20 mg/g of polyphenols was provided by Nutrexpa 
S.L. CocoaPure containing 510 mg/g of polyphenols was provided by Naturex Spain S.L. The three 
cocoa diets were prepared from a basal mix diet and particular components, both supplied by Teklad 
Global Diets (Harlan, Indianapolis, IN, USA). The addition of 100 g/kg of conventional cocoa,  
8.7 g/kg or 17.8 g/kg CocoaPure was established in order to obtain a final diet with 0.2%, 0.4% and 
0.8% of polyphenols, respectively, and the same proportion of macronutrients as AIN-93M formula. 
(Table 1). The polyphenol characterization of PC0.2, PC0.4 and PC0.8 diets is also summarized in 
Table 1. 
Table 1. Composition of experimental diets (g/kg diet). The three experimental diets provided 
similar amounts of proteins, lipids and carbohydrates to the reference diet (AIN-93M). 
Components REF (AIN-93M; g/kg) PC0.2 (g/kg) PC0.4 (g/kg) PC0.8 (g/kg) 
Cocoa powder - 100 8.7 17.4 
Nutrients provided  
by the basal mix: 
Casein 
 
 
121.8 
 
 
97.1 
 
 
120.7 
 
 
119.5 
L-Cystine 1.8 1.4 1.8 1.8 
Corn Starch 419.1 421.0 418.3 417.5 
Maltodextrin 147.3 116.8 147.3 147.3 
Sucrose 117.0 108.7 117.0 117.0 
Soybean oil 40.0 26.2 39.4 38.9 
Cellulose 50.0 24.5 48.3 46.5 
Minerals 27.0 27.8 27.0 27.0 
Vitamins 2.0 7.2 2.0 2.0 
Choline bitartrate 2.5 2.0 2.5 2.5 
tert-Butylhydroquine 0.008 0.006 0.008 0.008 
Nutrients provided  
by cocoa powder: 
Protein 
 
 
- 
 
 
22 
 
 
1.13 
 
 
2.26 
Carbohydrate - 16 0.82 1.64 
Lipid - 11 0.56 1.12 
Fiber (insoluble/soluble) - 34 (25.5/8.5) 1.75 (1.31/0.44) 3.5 (2.63/0.88) 
Total polyphenols * - 2.12 4.44 8.88 
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Table 1. Cont. 
Polyphenols provided  
by cocoa powder **: 
Catechin 
 
 
- 
 
 
0.073 
 
 
0.048 
 
 
0.097 
Epicatechin - 0.204 0.689 1.379 
Isoquercetin - 0.0053 n.d. n.d. 
Quercetin - 0.0029 n.d. n.d. 
Procyanidin B1 - n.d. 0.127 0.254 
Procyanidin B2 - 0.167 0.356 0.713 
Total procyanidins - n.d. 3.897 7.795 
* The analytical method employed to estimate the total polyphenol compounds was the spectrophotometric 
method of Folin-Ciocalteu [26]. ** Polyphenol profile was identified and quantified using a reversed-phase 
high performance liquid chromatography (RP-HPLC) coupled to a diode array detector (DAD)  
(RP-HPLC-DAD) [27], and procyanidin B1 and B2 were quantified by normal-phase HPLC coupled to mass 
spectrometry (MS) [9] with fluorescence detection (n.d. means non determined). 
Animals were given free access to water and chow. Body weight and food intake were monitored 
twice per week throughout the experiment. Studies were performed according to the criteria outlined 
by the Guide for the Care and Use of Laboratory Animals. Experimental procedures were reviewed 
and approved by the Ethical Committee for Animal Experimentation of the University of Barcelona. 
2.2. Sample Collection and Processing 
From the beginning of the diet until the end of the study, blood was collected through the saphenous 
vein and, after centrifugation, serum was separated and kept at −20 °C until ELISA quantification. 
Fecal samples were collected at the same time points and kept at −20 °C until analysis. Fecal 
homogenates for bacteria proportion and immunoglobulin-coating bacterial analysis (5% w/v) and 
ELISA IgA quantification (2% w/v), were obtained as previously described [19,20] and frozen at  
−20 °C until analysis. 
2.3. Fecal pH Determination 
Feces collected at the beginning and at the end of the nutritional intervention were used to 
determine fecal pH using a surface electrode (Crison Instruments, S.A., Barcelona, Spain). 
2.4. Immunoglobulin Quantification in Serum and Feces (ELISA) 
Fecal IgA, serum IgM and IgG concentrations were quantified by ELISA as previously  
described [28]. In brief, 96-well polystyrene plates (Nunc Maxisorp, Wiesbaden, Germany) were 
coated with anti-rat IgA, IgM or IgG mAbs (BD Biosciences, Heidelberg, Germany) (2 mg/mL in 
phosphate-buffered saline, PBS) and, after blocking with 1% bovine serum albumin (BSA,  
Sigma-Aldrich, Madrid, Spain) in PBS (PBS-BSA, 1 h, room temperature), appropriate diluted 
samples and standard dilutions (purified IgA, IgM or IgG, BD Biosciences) were added. After 
washing, biotin-conjugated anti-rat IgA, IgM or IgG mAbs (BD Biosciences) and subsequently,  
peroxidase-conjugated ExtrAvidin (Sigma-Aldrich) was added. An o-phenylenediamine 
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dihydrochloride-H2O2 solution (Sigma-Aldrich) was used for the detection of bound peroxidase.  
3 M H2SO4 was added to stop the reaction. Optical density (OD) was measured on a microtiter 
microplate photometer (Labsystems Multiskan, Helsinki, Finland) at 492 nm. Data were interpolated 
by means of Ascent v.2.6 software (Thermo Fisher Scientific, S.I.U., Barcelona, Spain) into the 
standard curves, and expressed as µg/mL in serum and as ng/mL in faecal samples. 
2.5. Fecal Bacteria and IgA-Coating Bacterial Analysis 
A volume of 35 µL of the fecal homogenates was diluted in 500 μL 1% (v/v) fetal bovine serum 
(FBS)/PBS and, after centrifugation (8000 g, 5 min, 4 °C), the resulting pellet was resuspended in  
50 µL 1% (v/v) FBS/PBS containing fluorescein isothiocyanate (FITC)-anti-rat Ig antibodies  
(Abcam, Cambridge, UK). Each mixture was incubated for 30 min in the dark at room temperature.  
A non-stained mixture of each sample was used as control. Thereafter, suspensions were washed twice 
with PBS (8000 g, 5 min) and resuspended in 200 µL PBS until analysis. The labeled samples were 
mixed with 10 µL propidium iodide (PI, Sigma–Aldrich) (1 mg/mL) 15 min prior to flow cytometry 
(FCM) analysis in order to label total bacteria [19]. A FacsAria SORP sorter (BD, San José, CA, USA) 
was used. The FCM parameters were adjusted to obtain particle counts of 100–1000 events per second 
and the events were recorded for 60 s in list mode files. Data analysis was performed using the FlowJo 
v7.6.5 software (Tree Star, Inc., Ashland, OR, USA). 
For bacteria proportion evaluation, a gate according to forward- and side-scattered light (FSC/SSC) 
was established on the basis of bacteria morphology from previous studies by using specific rRNA 
probes. The percentage of events stained with PI (by means of 610/20 nm fluorescence detectors) 
inside this gate is indicative of the proportion of bacteria present in the fecal sample. For IgA-coating 
bacteria, FITC-anti-rat Ig bound to bacteria were detected with the FITC fluorescence detectors 
(530/30 nm) and the IgA-coating bacteria proportion was expressed as positive FITC counts within the 
PI positive bacteria present in the above FSC/SSC morphology gate. Previously, we had demonstrated 
that Ig coated to bacteria was exclusively IgA [19]. 
2.6. Statistical Analysis 
The software package SPSS 20.0 (SPSS, Inc., Chicago, IL, USA) was used for statistical analysis. 
Levene’s and Kolmogorov-Smirnov’s tests were applied to evaluate the equality of variance and 
normal distribution assays of the studied groups, respectively. The two-way analysis of variance 
followed by Bonferroni’s post hoc significance test was used when the assumptions of normality and 
equal variance were found in variables along time (i.e., weight, chow intake, IgG). In the opposite 
case, non-parametric tests (Kruskall-Wallis and Mann-Whitney U rank-sum test) were used to assess 
significance (i.e., IgM and IgA). Moreover, the non-parametric Wilcoxon test was used to compare 
matched groups at unique time point (i.e., total bacteria at the end of the period). Significant 
differences were established at P values less than 0.05 when comparing two variables, and less than 
0.0167 when comparing four variables (i.e., four experimental diets). 
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3. Results 
3.1. Body Weight and Chow Intake 
During the study, the body weight slope was similar between the groups with the exception of 
animals, which received the diet with a lower polyphenol content (PC0.2 group) who showed a lower 
increase than that of the reference rats, being statistically significant at the end of the study (Figure 1a). 
This effect was not related to a lower chow intake, as chow intake in all polyphenol-enriched groups 
and in the reference group ranged from 5 to 9 g/100 g/day, with no statistical differences between them 
(Figure 1b). 
Figure 1. (a) Body weight and (b) chow intake (g/100 g rat/day) monitored during the 
period of dietary intervention with the cocoa polyphenol-enriched diets. Values are expressed 
as mean ± SEM (n = 6). Statistical differences: * p < 0.0167 vs. reference group (REF). 
 
3.2. Serum IgG and IgM Concentrations 
Serum concentrations of IgG and IgM from all experimental groups throughout the study are 
summarized in Figure 2. Although none of the cocoa polyphenol-enriched diets was able to 
significantly modify the serum IgG concentration, all dietary interventions had a tendency to lower the 
age-increasing pattern (Figure 2a). With regards to serum IgM antibodies, the animals fed with PC0.4 
diet showed a significant decrease of IgM concentration two weeks after cocoa polyphenol intake 
began (Figure 2b) compared to those of the REF and PC0.2 groups (p < 0.0167). 
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Figure 2. Effects of cocoa polyphenol-enriched diets on serum IgG (a) and IgM  
(b) concentrations at the beginning, and after one and two weeks of diet. Values are 
expressed as mean ± SEM (n = 6). Statistical differences: * p < 0.0167 vs. REF and  
φ p < 0.0167 vs. cocoa group (PC)0.2. 
 
3.3. Fecal IgA Concentration 
Intestinal IgA production was quantified in feces. The fecal IgA concentration increased about  
four-fold over the study period in REF rats. Overall, this age-dependent increase was avoided by all 
cocoa polyphenol-enriched diets. IgA concentrations were already lower than in the REF group one 
week after nutritional intervention in the PC0.2 and PC0.8 groups (p < 0.0167) and remained 
significant until the end of the study (Figure 3). 
Figure 3. Effect of cocoa polyphenol-enriched diets on fecal IgA concentration at the 
beginning of the study and after one and two weeks of dietary intervention. Values are 
expressed as mean ± SEM (n = 6). Statistical differences: * p < 0.0167 vs. REF. 
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3.4. Total Bacteria Determination 
Fecal samples collected at the beginning of the diet and two weeks after the nutritional intervention 
allowed us to determine the percentage of total bacteria. For that, bacteria morphology was selected 
according to their FSC/SSC signal and by means of PI fluorescence detectors (Figure 4a). There was 
no difference in the percentage of total bacteria in any of the groups at the baseline (55.45% ± 1.46%).  
The REF group showed a significant age-related increase in this percentage, from ~55% at the 
beginning of the diet to ~62% two weeks later (p < 0.05). This pattern was avoided by all cocoa 
polyphenols-enriched diets regardless of dose (p < 0.0167) (Figure 4b). 
Fecal samples collected weekly allowed fecal pH to be determined (Figure 4c). Although there were 
some punctual differences at Day 7 for the PC0.2 diet and at the end of the study for PC0.8,  
no significant changes due to the nutritional interventions of cocoa were observed and a similar pattern 
was seen for pH. 
Figure 4. Representative biparametric cytogram showing the initial acquisition gate to 
select the bacterial population according to its forward- and side-scattered light (FSC/SSC) 
signal with the mean ± SEM of all groups at the baseline (a). Effect of cocoa  
polyphenol-enriched diets on total bacteria (b) and fecal pH (c) after two weeks of 
nutritional intervention. Results are expressed as mean ± SEM (n = 6). Statistical 
differences: δ p < 0.05 vs. initial values, * p < 0.0167 vs. REF, φ p < 0.0167 vs. PC0.2 and 
ω p < 0.0167 vs. PC0.4 in same day of study. 
 
3.5. IgA-Coating Bacteria Analysis 
IgA-coating bacteria were determined by flow cytometry using fecal samples collected before the 
start of the diet and at the end of the study (Figure 5). A non-stained sample was used as a negative 
control (Figure 5a). At the beginning, all groups showed a similar IgA-coating pattern (Figure 5b).  
The REF group showed an age-related increase in the percentage of IgA-coating bacteria from up to 
~38% two weeks later (Figure 5c). This pattern was avoided by all cocoa polyphenol-enriched diets  
(p < 0.0167) (Figure 5d–f) with the down modulatory effect in animals that received the diet with a 
lower polyphenol content (PC0.2 group, p < 0.0167) (Figure 5d) being significantly higher. 
 
Diet days
0 3 7 10 14
p
H
5.0
5.5
6.0
6.5
7.0
7.5
8.0
8.5
φ
*
φω
100 101 102 103 104
FSC-A
10 0
10 1
10 2
10 3
10 4
S
S
C
-A
104
103
102
101
100
100 101 102 103 104
a.
S
S
C
FSC 
55.45± 1.46
c.
REF PC0.2 PC0.4 PC0.8PC0.8 PC0.4 REF PC0.2 
Diet days
0 14
T
o
ta
l 
B
a
c
te
ri
a
 (
%
)
0
10
20
30
40
50
60
70
* δδδ* *
b.
Nutrients 2013, 5 3280 
 
Figure 5. Effects of cocoa polyphenol-enriched diets on percentage of fecal bacteria  
coated with IgA before and after 2 weeks of nutritional intervention. Biparametric 
cytogram corresponding to a negative fecal control (a). It combines morphological 
parameters of the bacterial population (FSC/SSC) and fluorescence for IgA-fluorescein 
isothiocyanate (FITC) which allow the threshold for the positive region to be established. 
Cytogram, which represents the percentage of IgA-coating bacteria at baseline for all 
groups (b). Cytograms for IgA-coating bacteria detection for REF (c), PC0.2 (d), PC0.4  
(e) and PC0.8 (f) groups at the end of the study. Results are expressed as  
mean ± SEM (n = 6). 
 
4. Discussion 
In previous studies, cocoa-enriched diets have demonstrated their immunomodulatory role on rats’ 
systemic and intestinal compartments. It is believed that this effect is mainly due to the polyphenols 
present in cocoa. The purpose of the present work was focused on investigating whether these effects 
are attributed exclusively to its polyphenol content or to other compounds present in cocoa. For that, 
Lewis rats were fed three cocoa diets formulated with two distinct cocoa raw materials differing in 
polyphenol dose and composition. The study lasted two weeks, because in previous studies, this period 
was enough to down-regulate intestinal IgA [20]. From the present results it emerges that all dietary 
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interventions with cocoa attenuated the humoral intestinal immune response, demonstrating for the 
first time the immunomodulatory effect of non-fermented-polyphenolic-enriched cocoa. Although all 
dietary interventions with cocoa attenuated the humoral intestinal immune response, it was achieved in 
a polyphenol-dose-independent manner suggesting that other compounds present in cocoa powder also 
play a role. 
Previous reports concerning the effect of cocoa on the immune system in vivo have been developed 
using 2%–10% cocoa-enriched diets formulated with defatted cocoa containing 20–30 mg/g of 
polyphenols [19–21]. In the present study we used a conventional cocoa powder with 2% of 
polyphenols to elaborate the PC0.2 diet. We added 100 g of cocoa powder to 900 g of basal mix and 
the resulting diet contained 0.2% polyphenols in addition to the proteins (2.2%), carbohydrates (1.6%), 
lipids (1.1%) and fiber (3.5%) provided by cocoa. The present work includes the study of the effect of 
CocoaPure, which is a cocoa powder obtained by a modification of conventional cocoa powder 
processing, thus avoiding the loss and keeping the high amount of polyphenols present in the cocoa  
seed [26]. In the elaboration of the CocoaPure diets (PC0.4 and PC0.8), a small amount of cocoa 
powder was used to double or to quadruple the polyphenol content of the conventional 10% cocoa diet 
(PC0.2). As about 50% of CocoaPure corresponded to polyphenols, the PC0.8 diet contained only 
0.23% cocoa proteins, 0.16% cocoa carbohydrates, 0.11% cocoa lipids and 0.35% cocoa fiber, whereas 
the PC0.4 diet contained half proportions of these nutrients. Therefore, in the present study, three 
cocoa diets with increasing proportions of polyphenols (0.2%–0.8%) and decreasing content of other 
cocoa compounds, such as fiber, were designed to dissect the effects of cocoa polyphenols on the 
immune system. 
During the study, all the rats fed the cocoa polyphenol-enriched diets had similar chow intakes to 
the reference animals. However, the animals in the PC0.2 group had lower body weight increase than 
the reference group during the study. These results are similar to those previously shown in high-dose 
cocoa-fed rats [17,21]. In this regard, flavonoids seem to stimulate cellular energy [29,30], cocoa 
intake is capable of inhibiting the lipid digestion and absorption [31–33] or of reducing fat  
deposition [33–36]. However, in the present study, the conventional cocoa diet (PC0.2), which 
provided the lowest amount of polyphenols, was the diet with the strongest effect on body weight. This 
result suggests that other compounds present in cocoa, such as fiber might also contribute to the 
inhibitory potency of the polyphenols [37]. Additionally the kind of flavonoids (monomeric, 
oligomeric or polymeric flavanols) contained in cocoa materials could also play a role in this effect on 
body weight increase. Another possible mechanism involved in the cocoa’s ability to reduce body 
weight and in lipid metabolism may be the polyphenols’ effect on microbiota composition. Differential 
effects of gut bacteria on the efficiency of energy extraction from the diet and changes in the host 
metabolism of absorbed calories have been described [38,39] and, for example, a high  
Firmicutes-to-Bacteroidetes ratio might have an important role in obesity [39–41]. In this sense, 
previous studies have demonstrated that cocoa reduces the Clostridium and Staphylococcus genera 
belonging to the Firmicutes phylum in the gut microbiota [19]. Although in the present study changes 
in microbiota composition were not evaluated, a reduction in the proportion of bacteria in feces was 
found in all the animals fed with cocoa polyphenol diets whereas no significant change in fecal pH was 
observed. This effect could be attributed to the antimicrobial activity of polyphenols, which has been 
reported both in vitro [42–44] and in experimental animals [45,46]. Focusing on cocoa polyphenols, 
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our findings regarding the decreasing percentage of total bacteria seem to be in accordance with a 
previous study showing that polyphenols present in cocoa can produce an inhibitory effect on the 
growth of certain gut microbiota in rats [19]. Nevertheless, other studies have shown the ability of 
certain flavonoids present in cocoa to promote the growth of selected bacteria genera [47,48]. In any 
case, further studies should be carried out to look in detail at the effects of cocoa polyphenols on the 
microbiota composition and metabolism. 
Regarding the systemic humoral response, previous studies have shown that immunoglobulin 
production is attenuated by experimental cocoa-enriched diets. Thus, splenocytes from young rats fed 
cocoa had a lower capacity to produce IgG, IgM and IgA and cocoa-fed rats had decreased serum IgG, 
IgM and IgA concentrations [17,18]. However, in the present study carried out in older rats for  
two weeks, all cocoa polyphenol diets tested had a tendency to lower the age-increasing pattern 
observed in the reference group but without significant differences and lacking a polyphenol  
dose-dependent effect. Therefore, it can be concluded that when the cocoa diet begins later in life and 
it lasts just two weeks, the immunomodulating effect is not as clear as in early age. We cannot discard 
the idea that a longer exposure to cocoa diet might have a more significant effect. A lack of or low 
effect has also been described when the cocoa proportion included in the diet was lower [28]. 
Contrary to what happened in the systemic compartment, the suppressing effect of cocoa 
polyphenols on antibody concentration was higher in the intestinal compartment. Our results from a 
defatted conventional cocoa diet (PC0.2) confirmed the down-modulatory effect on intestinal IgA 
content shown in previous studies, including varied proportions of cocoa diets (2%–10%), different 
ages at the beginning of the dietary intervention (3–6 weeks old) and length of diet  
(3–9 weeks) [17,18,28]. In the same way, the PC0.4 and PC0.8 diets, with a higher polyphenol  
content than the above-mentioned diet, also drastically decreased the IgA production but without a 
polyphenol dose-dependent effect. The effect of cocoa on intestinal IgA could be due, as has been 
described, to the influence of cocoa on genes related to Th maturation, Th-B cell interactions, and 
IgA+ B cell gut homing, among others [18,28]. Regardless of the cocoa-induced mechanisms, 
antibody-attenuating effects have also been previously described for different dietary polyphenols such 
as genistein [49], luteolin [50] and apigenin [51] in healthy or hypersensitivity animal models. 
With regards to IgA-coating bacteria, similar results to the intestinal IgA content were found. The 
lowering effect of a defatted cocoa polyphenol diet (PC0.2) on IgA-coating bacteria in old animals 
agrees with previous studies performed on younger animals [19]. Again, there was a lack of correlation 
between the total polyphenol content in the diet and IgA-modulating effects, which means that cocoa 
diets based on higher flavonoids/lower cocoa fiber (CocoaPure) displayed similar effects. Therefore, 
the intestinal IgA down-modulatory effects described here could be partially attributed to cocoa 
polyphenols, because all diets, even with a very low cocoa fiber content (PC0.4 and PC0.8), were able 
to modulate the intestinal IgA production. However, a particular effect according to the kind of 
flavanols found on conventional or unfermented cocoa matter cannot be discarded. 
In any case, a high whole cocoa or cocoa polyphenol intake might play an immunoregulatory role 
that could be beneficial on the hypersensitivity status. The immunomodulatory ability of cocoa can be 
especially significant in diseases involving a dysregulation of intestinal antibody responses such as 
celiac disease or food allergies. 
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5. Conclusions 
The immunomodulatory effects of diets containing high cocoa could be partially attributed to its 
polyphenol content. However, other cocoa compounds and the particular polyphenol composition 
could also be key factors in this effect. Further studies evaluating dissected components of cocoa, such 
as individual polyphenols, fiber, theobromine, etc. should be carried out in order to evaluate whether it 
is possible to reproduce, at least partially, the previously and herein described cocoa effects on the 
immune system. 
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